Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restrictive vs liberal oxygen strategy in ARDS patients
2015-004709-17Phase 4Completed
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxygen in acute respiratory distress syndrome (ARDS) (2 arms). Primary endpoint: 28-day mortality. Started Feb 2016; status: completed.
02
Drugs
oxygen
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2015-004709-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004709-17.